TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study.

Dmitriy Zamarin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.